Isao Ohsawa
Soka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Long-Term Integrated Safety and Efficacy of Garadacimab for Hereditary Angioedema Prophylaxis.
Journal: Advances in therapy
Published: February 23, 2026
Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-S.
Journal: The journal of allergy and clinical immunology. Global
Published: December 01, 2025
Spontaneous hemorrhage from a functionally well-controlled, non-enlarged but hyperplastic parathyroid gland due to secondary hyperparathyroidism: a case report.
Journal: CEN case reports
Published: July 12, 2025
A nationwide questionnaire-based surveillance on pediatric hereditary angioedema in Japan.
Journal: Pediatrics international : official journal of the Japan Pediatric Society
Published: May 09, 2024
Assessment of communication environment and health literacy of patients on chronic hemodialysis: a multicenter observational study (SMEL-HD study).
Journal: Clinical and experimental nephrology
Published: November 05, 2023
Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trial.
Journal: The World Allergy Organization journal
Published: October 27, 2023
Multidisciplinary Prophylactic Strategies for Recurrence of Laryngeal Edema After Tooth Extraction in a Patient With Hereditary Angioedema: A Case Report.
Journal: Cureus
Published: October 11, 2023
Rapidly progressive cognitive impairment resulting in heavy psychosocial burden in a patient with Fabry disease undergoing hemodialysis: a case report.
Journal: BMC nephrology
Published: September 26, 2023
Gut Microbiome and Microbiome-Derived Metabolites in Patients with End-Stage Kidney Disease.
Journal: International journal of molecular sciences
Published: May 19, 2023
Fibrin and fibrinogen degradation products/D-dimer ratio can be a useful marker for differentiating an acute attack of hereditary angioedema from thrombotic conditions.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: March 12, 2023
Efficacy and safety of lanadelumab in Japanese patients with hereditary angioedema: A phase 3 multicenter, open-label study.
Journal: The Journal of dermatology
Published: March 03, 2023
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: Lancet (London, England)
Published: January 23, 2023
Last Updated: 09/26/2026